President Trump signed an executive order to end gender-affirming medical treatments for children under 19, restricting surgeries, hormone therapy, and other regimens, further diminishing social protections for transgender individuals and directing agencies to limit gender-related procedures. The order also targeted insurance coverage under Medicare, Medicaid, and the Affordable Care Act, aiming to halt some gender-affirming care, while instructing federal research and education grant recipients to refrain from providing such procedures. Civil rights groups condemned the administration’s actions, citing the life-saving benefits of gender-affirming care for trans youth, as the administration continued to portray these treatments in a negative light, with the order referring to procedures as “chemical and surgical mutilation.”
Full Article
Loading PerspectiveSplit analysis...
